http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007502313-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 |
filingDate | 2004-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2007502313-A |
titleOfInvention | New 14- and 15-membered ring compounds |
abstract | [Chemical 1] The present invention relates to a 4 ″ -substituted 14-membered or 15-membered macrolide of formula (I) and a pharmaceutically acceptable derivative thereof, a process for producing the same, and the treatment or prevention of systemic or local microbial infections in the human or animal body. Related to its use. |
priorityDate | 2003-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.